Fill-Finish and Packaging Services

The contract entails providing sterile vial filling, lyophilization when applicable, labeling, and secondary packaging services for clinical or commercial vaccine supplies, all conducted under current Good Manufacturing Practices (cGMP). It is categorized as a subcontract and falls under the NAICS code 325412, which pertains to pharmaceutical manufacturing. The work is to be performed in Washington, with a focus on meeting stringent quality and regulatory standards suitable for vaccine production. Issued by the Department of Health and Human Services through the Biomedical Advanced Research and Development Authority (BARDA), the contract supports vaccine supply chain needs for government health initiatives. The solicitation was posted on June 3, 2026, with a response deadline set for July 15, 2026. The contract emphasizes compliance with regulatory requirements and aims to ensure timely and quality delivery of vaccine-related filling and packaging services to support clinical trials or commercial distribution.